AIC
CRL icon

Ameritas Investment Company’s Charles River Laboratories CRL Stock Holding History

Ameritas Investment Company’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,888
Closed -$837K – 997
2021
Q1 		$837K Buy
+2,888
New +$803K 0.07% 253
2020
Q2 		– Sell
-4
Closed – – 545
2020
Q1 		$0 Buy
+4
New +$600 ﹤0.01% 1766

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Ameritas Investment Company's CRL Position: Q2 2021 in Review

Ameritas Investment Company sold out of Charles River Laboratories (CRL) in Q2 2021, closing a stake of 2,888 shares — an estimated $837K sold.

Ameritas Investment Company first reported a position in CRL in Q1 2020 and held it in 2 quarters. The position peaked at $837K in Q1 2021. 639 funds tracked by Wall St. Rank hold CRL as of Q2 2021.

  • Ameritas Investment Company reported no remaining Charles River Laboratories position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Company sold 2,888 Charles River Laboratories shares in Q2 2021, an estimated $837K.
  • Ameritas Investment Company first reported a position in Charles River Laboratories in Q1 2020 and held it in 2 quarters.
  • Ameritas Investment Company's Charles River Laboratories position peaked at $837K in Q1 2021.
  • 639 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.